Nation | by AFP
New Delhi,
India will carry out a deeper review of post-vaccination side effects from the AstraZeneca shot next week although no cases of blood clots have been reported so far, an official told AFP Saturday.
New Delhi decided to conduct the review after several countries suspended rollout over blood clot fears even as the World Health Organization said there was no reason to stop using AstraZeneca’s Covid-19 jab.
Denmark, Norway and Iceland paused use of the drug maker’s shot as a precaution after isolated reports of…
